Pharmafile Logo
Pharmafocus logo
Advanced Search

Efient

Showing 6 posts of 6 posts found.

Lilly image

NICE extends recommendation for Efient

July 24, 2014
Sales and Marketing ACS, Efient, NICE, Plavix, longs ton, prasugrel

In updated guidance NICE has extended its recommendation of Efient (prasugrel) in combination with aspirin for preventing blood clots in …

News
Lilly image

Lilly’s Efient tipped for expanded NICE approval

June 20, 2014
Sales and Marketing Effient, Efient, FDA, NHS, blood, lilly, longston, thinner

 Eli Lilly’s anti-platelet drug Efient has been given the nod by UK healthcare watchdog NICE for more widespread use, pending …

News

Efient fails to prove superiority to Plavix

August 29, 2012
Brillinta, Efient, Plavix, prasugrel, ticagrelor

Daiichi Sankyo and Lilly’s heart drug Efient has failed to come up to the mark in a late-stage trial which …

News

Merck’s vorapaxar fails in late-stage trial

November 15, 2011
ACS, Brilinta, Efient, Merck, Plavix, antiplatelet, vorapaxar

Merck’s novel blood thinner vorapaxar has failed to meet its primary endpoint in a late-stage study.The TRACER trial compared vorapaxar …

News

NICE backs limited use of Lilly’s Plavix rival

September 7, 2009
Research and Development Efient, NICE

 NICE has recommended Lilly and Daiichi’s Efient for use on the NHS, giving the blood-thinner drug a boost in its …

News

Companies try to quell rumours on prasugrel

October 17, 2008
Sales and Marketing Efient, lilly

Daiichi-Sankyo and Lilly have responded to media speculation around the FDA's make-or-break ruling on their major new drug prasugrel. The …

News
The Gateway to Local Adoption Series

Latest content

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026